Search Results - "Sunami, E."

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial by Yamazaki, K., Yamanaka, T., Shiozawa, M., Manaka, D., Kotaka, M., Gamoh, M., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Sunami, E., Ohtsu, A., Maehara, Y., Yoshino, T.

“…Oxaliplatin-based adjuvant chemotherapy may be associated with debilitating peripheral sensory neuropathy (PSN) in patients with high-risk stage II colon…”
Get full text

Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: A multicenter retrospective study by Kawai, K, Ishihara, S, Yamaguchi, H, Sunami, E, Kitayama, J, Miyata, H, Sugihara, K, Watanabe, T

“…Abstract Purpose Although stage IV colorectal cancer (CRC) encompasses a wide variety of clinical conditions with diverse prognoses, no statistical model for…”
Get full text

Surgical stress response after colorectal resection: a comparison of robotic, laparoscopic, and open surgery by Shibata, J., Ishihara, S., Tada, N., Kawai, K., Tsuno, N. H., Yamaguchi, H., Sunami, E., Kitayama, J., Watanabe, T.

“…Background The perioperative immune status of colorectal robotic surgery (RS), laparoscopic surgery (LS), and open surgery (OS) patients has not been compared…”
Get full text

Appendiceal orifice inflammation is associated with proximal extension of disease in patients with ulcerative colitis by Anzai, H., Hata, K., Kishikawa, J., Ishii, H., Yasuda, K., Otani, K., Nishikawa, T., Tanaka, T., Kiyomatsu, T., Kawai, K., Nozawa, H., Kazama, S., Yamaguchi, H., Ishihara, S., Sunami, E., Watanabe, T.

“…Aim Ulcerative colitis (UC) is considered to be a disease of continuous mucosal inflammation extending proximally from the rectum. However, appendiceal orifice…”
Get full text

Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression by Anzai, H., Hata, K., Kishikawa, J., Ishii, H., Nishikawa, T., Tanaka, T., Tanaka, J., Kiyomatsu, T., Kawai, K., Nozawa, H., Kazama, S., Yamaguchi, H., Ishihara, S., Sunami, E., Kitayama, J., Watanabe, T.

“…Aim The rate of extension of proctitis in Western countries has been reported, but no data regarding long‐term follow‐up have been described for the Japanese…”
Get full text

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer by TOMOZAWA, S, TSUNO, N. H, SUNAMI, E, HATANO, K, KITAYAMA, J, OSADA, T, SAITO, S, TSURUO, T, SHIBATA, Y, NAGAWA, H

“…Epidemiological studies have demonstrated that nonsteroidal anti-inflammatory drugs (NSAIDs), known to inhibit cyclooxygenase (COX), reduce the risk of…”
Get full text

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522 by TOMOZAWA, S, NAGAWA, H, TSURUO, T, SHIBATA, Y, MUTO, T, TSUNO, N, HATANO, K, OSADA, T, KITAYAMA, J, SUNAMI, E, NITA, M. E, ISHIHARA, S, YANO, H

“…It is proposed that non-steroidal anti-inflammatory drugs (NSAIDs) reduce colorectal tumorigenesis by inhibition of cyclooxygenase (COX). COX is a key enzyme…”
Get full text

Six cases of primary colorectal cancer after living-donor liver transplantation: a single-institution experience in Japan by Kazama, Shinsuke, Hongo, Kumiko, Sunami, Eiji, Sugawara, Yasuhiko, Kokudo, Norihiro, Kitayama, Joji

“…Liver-transplant patients have an increased risk of developing primary malignancies, possibly due to prolonged immunosuppression. However, no information on…”
Get full text

MMP‐1 is a Prognostic Marker for Hematogenous Metastasis of Colorectal Cancer by Sunami, Eiji, Tsuno, Nelson, Osada, Takuya, Saito, Shinsuke, Kitayama, Joji, Tomozawa, Shigeru, Tsuruo, Takashi, Shibata, Yoichi, Muto, Tetsuichiro, Nagawa, Hirokazu

“…Background. Degradation of basement membrane and extracellular matrix by matrix metalloproteinases (MMPs) is believed to be an essential step in the…”
Get full text

A case of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) with multiple polyps arising in the cecum and appendix by Kaneko, M, Nozawa, H, Kitayama, J, Sunami, E, Akahane, M, Yamauchi, N, Furukawa, Y, Nagawa, H

“…We present the case of a 32-year-old female with cecal and appendiceal polyps that were removed by laparoscopy-assisted surgery. She also had recurrent…”
Get more information

Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow by KITAYAMA, J, NAGAWA, H, TSUNO, N, OSADA, T, HATANO, K, SUNAMI, E, SAITO, H, MUTO, T

“…Under the physiological shear condition, cultured colon cancer cells bound to laminin (LM), but not to fibronectin or vitronectin. Most of the tethered cells…”
Get full text

A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model by Yoneyama, S, Okaji, Y, Tsuno, N.H, Kawai, K, Yamashita, H, Tsuchiya, T, Yamada, J, Sunami, E, Osada, T, Kitayama, J, Takahashi, K, Nagawa, H

“…Abstract Aim Historically, cancer therapy directly targeting tumor cells have yielded suboptimal clinical results, and therefore anti-angiogenic therapy that…”
Get full text

E-selectin can mediate the arrest type of adhesion of colon cancer cells under physiological shear flow by Kitayama, J, Tsuno, N, Sunami, E, Osada, T, Muto, T, Nagawa, H

“…The aim of this study was to determine whether colon cancer cells flowing in blood exhibit the same adhesion pattern to the vascular bed as leucocytes using a…”
Get full text

Morphological Characteristics of Schwann Cells in the Islets of Langerhans of the Murine Pancreas by SUNAMI, Eiji, KANAZAWA, Hiroaki, HASHIZUME, Hiroya, TAKEDA, Masaei, HATAKEYAMA, Katsuyoshi, USHIKI, Tatsuo

“…The present study demonstrated the three-dimensional architecture of peri-insular nerve plexuses in the murine pancreas by the combined use of light microscopy…”
Get full text

414P Long-term follow-up of the randomized trial of the conventional technique versus the no-touch isolation technique for primary tumor resection in patients with colon cancer ( JCOG1006) by Takii, Y., Mizusawa, J., Kanemitsu, Y., Komori, K., Shiozawa, M., Ohue, M., Ikeda, S., Takiguchi, N., Kobatake, T., Ike, H., Sato, T., Tomita, N., Ota, M., Sunami, E., Hamaguchi, T., Shida, D., Katayama, H., Shimada, Y., Fukuda, H.

Get full text

323P Five-year efficacy and safety in a randomized phase III trial investigating duration of adjuvant oxaliplatin-based therapy (3- vs. 6-months) for patients with high-risk stage II colon cancer: ACHIEVE-2 trial by Makiyama, A., Yamazaki, K., Shiozawa, M., Manaka, D., Kotaka, M., Sakamoto, Y., Shiomi, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Takashi, U., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Misumi, T., Sunami, E., Ohtsu, A., Maehara, Y., Yoshino, T.

Get full text

407P Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for high-risk stage II colon cancer: ACHIEVE-2 as part of the IDEA collaboration by Kotaka, M., Shiozawa, M., Manaka, D., Sakamoto, Y., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Yamanaka, T., Sunami, E., Yamazaki, K., Ohtsu, A., Maehara, Y., Yoshino, T.

Get full text

415P Prognostic effect of postoperative serum carcinoembryonic antigen (CEA) combined with T4 versus T3 tumors in patients with high-risk stage 2 colon cancer: ACHIEVE-2 phase III randomized clinical trial by Shiomi, A., Shiozawa, M., Manaka, D., Kotaka, M., Sakamoto, Y., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Yamanaka, T., Sunami, E., Yamazaki, K., Ohtsu, A., Maehara, Y., Yoshino, T.

Get full text

525OACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC) by Yoshino, T, Yamanaka, T, Shiozawa, M, Manaka, D, Kotaka, M, Gamoh, M, Shiomi, A, Makiyama, A, Munemoto, Y, Rikiyama, T, Fukunaga, M, Ueki, T, Shitara, K, Shinkai, H, Tanida, N, Yamazaki, K, Sunami, E, Ohtsu, A, Maehara, Y

“…Abstract Background The IDEA collaboration, a prospective pooled analysis of four concurrently conducted randomized phase III trials (SCOT, TOSCA, ACHIEVE-2,…”
Get full text

525O - ACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC) by Yoshino, T., Yamanaka, T., Shiozawa, M., Manaka, D., Kotaka, M., Gamoh, M., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Yamazaki, K., Sunami, E., Ohtsu, A., Maehara, Y.

“…The IDEA collaboration, a prospective pooled analysis of four concurrently conducted randomized phase III trials (SCOT, TOSCA, ACHIEVE-2, and HORG) for pts…”
Get full text